AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$1.12
−6.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.19x
- Price / sales
- 4.46x
- Price / cash flow
- -0.31x
Enterprise value
- Enterprise value
- $19.5M
- EV / sales
- 29.46x
- EV / EBITDA
- -2.44x
- EV / EBIT
- -2.28x
- Market cap
- $3.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026